Advertisement
Advertisement
NEW
Beova

Beova

Manufacturer:

Eisai

Distributor:

DKSH
Concise Prescribing Info
Contents
Vibegron
Indications/Uses
Symptomatic treatment of overactive bladder eg, urge urinary incontinence, urgency & frequency.
Dosage/Direction for Use
Administration
Should be taken with food.
Contraindications
Special Precautions
Discontinue use if urinary retention develops. Patients w/ lower urinary tract obstructive disease including benign prostatic hyperplasia; severe cardiac disease. Monitor patients w/ bladder outlet obstruction & taking muscarinic antagonists. Perform urinalysis & confirm clinical symptoms prior to use. Co-administration w/ CYP3A4 & P-gp inhibitors/inducers; digoxin. Not recommended in eGFR <30 mL/min/1.73 m2 on dialysis & eGFR <15 mL/min/1.73 m2 w/ or w/o hemodialysis. Severe hepatic impairment. Pregnancy & lactation. Childn. Elderly.
Adverse Reactions
Dry mouth, constipation; UTI, increased residual urine vol.
Drug Interactions
Increased Cmax & AUC0-24 of or w/ tolterodine. Increased Cmax & AUCinf w/ ketoconazole; diltiazem. Increased digoxin Cmax & AUC.
MIMS Class
Drugs for Bladder & Prostate Disorders
ATC Classification
G04BD15 - vibegron ; Belongs to the class of urinary antispasmodics.
Presentation/Packing
Form
Beova FC tab 50 mg
Packing/Price
28's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement